DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.

A genomic atlas of Nematostella vectensis reveals how primitive animals created multiple cell types millions of years ago, ...

Researchers at the Children's Cancer Institute and UNSW Sydney have tested a new way of treating childhood brain cancer by ...

For the last few years, the narrative around Generative AI in science has largely focused on administrative efficiency – ...

Researchers have tested a new way of treating childhood brain cancer by combining two medicines in lab studies, finding that ...

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...

Phase 1 study of REX-8756 is well underway following FDA clearance of the Investigational New Drug (IND) application in December 2025--In ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

New library of 400 immune-related factors and screening platform can find precise recipes for reprogramming accessible cells ...

By year-end 2028, submit new drug application evaluating cemsidomide and dexamethasone for potential accelerated approval in fourth line or later. In Q2 2026, initiate the Phase 1b trial of ...

A new CRISPR-based approach for tuning gene expression up and down allowed identification of how other genes' expression responds to changes of transcription factors.